DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the SANOFI INDIA LIMITED (SANOFI) share price today?

SANOFI INDIA LIMITED (SANOFI) is trading at ₹3,414.2 on the NSE, up 0.12% on the day. Source: DocStoX.

What is the PE ratio of SANOFI INDIA LIMITED?

SANOFI INDIA LIMITED has a price-to-earnings (PE) ratio of 24.0 in the Healthcare sector.

What is the market capitalisation of SANOFI INDIA LIMITED?

SANOFI INDIA LIMITED has a market capitalisation of approximately ₹7,860 crore.

SANOFI INDIA LIMITED

SANOFI·NSE·Healthcare

₹3,414.20▲ +4.10 (+0.12%)

Healthcare · Pharmaceuticals

Debt-free and consistently profitable

Day₹3370.20

₹3419.90

52W₹3054

₹604512%

Open

₹3419.00

High

₹3419.90

Low

₹3370.20

Prev Close

₹3410.10

Volume

12.9K

VWAP

₹3397.20

Snapshot

Key fundamentals

Market Cap

₹7,860 Cr

P/E Ratio

24.04Fair

P/B Ratio

10.31

EPS

₹142.04

Book Value

₹326.00

ROE

43.00%Strong

ROCE

58.00%Efficient

Dividend Yield

2.23%

Debt / Equity

0.02Low

Face Value

₹10.00

52W High

₹6044.50

52W Low

₹3054.00

Sector

Healthcare

Industry

Pharmaceuticals

Avoid

Narrow moatHigh uncertainty

Fair value estimate

₹809

▼ 76.3%downside

Trading at ₹3,414 — 76% above our estimate

BearFair valueBull

₹686₹809₹1,251

/100

Business quality — Solid

Growth 0Profitability 94Efficiency 50Valuation 82

Plain English

Our view

Debt-free and consistently profitable
Virtually debt-free balance sheet
Revenue has been shrinking

Strengths

Virtually debt-free balance sheet
Strong returns on equity (43%)
Capital is working hard (ROCE 58%)
Promoters hold a controlling stake

Risks

Revenue has been shrinking
Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

36% ROE fading to 12% over ~10 yrs, on ₹326 book

₹686

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹1,251

Analyst target

No analyst coverage

—

Blended fair value₹809

What the numbers say

Investment thesis

Bull case

Virtually debt-free balance sheet
Strong returns on equity (43%)
Capital is working hard (ROCE 58%)
Promoters hold a controlling stake

Bear case

Revenue has been shrinking
Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

24.0Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

43.0%Strong

Above 15% is considered healthy for Indian equities

ROCE

58.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.02Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹7,860 Cr

P/B

10.31

EPS

₹142.04

Div Yield

2.23%

What changed

Recent changes

Domestic institutions-0.2% stake last quarter

What matters

News impact

Overview

Valuation

Reasonable

P/E 24.0×

Growth

Shrinking

-11% rev CAGR

Profitability

Excellent

43.0% ROE

Financial health

Rock solid

D/E 0.02

Momentum

N/A

No technicals

Today

Trading activity

Delivery %51.9%

Turnover₹438.37L Cr

Trades5,352

VWAP₹3397.20

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

-10.7%

-7.3%

10Y

-1.5%

Profit

-19.6%

-19.8%

10Y

+0.3%

EPS

-6.7%

-12.3%

10Y

+4.9%

Profile

Pros

Company is almost debt free.
Company has a good return on equity (ROE) track record: 3 Years ROE 47.8%
Company has been maintaining a healthy dividend payout of 71.8%

Watch-outs

Cons

Stock is trading at 10.4 times its book value
The company has delivered a poor sales growth of -8.74% over past five years.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Domestic institutions reduced 0.18 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

60%

Promoter

Promoters

60.4%0.00

Public

10.2%+0.17

FII / FPI

5.6%+0.09

DII

21.1%-0.18

Others

2.6%

Total shareholders

75,758-55 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter60.40%

FII5.64%

DII21.13%

Public10.19%

Others2.64%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions